Steinhardt et al.[102], demonstrated that silvestrol reduced expression of components of the CBM complex (an upstream regulator of NF-κB) in B-lymphoma cell lines following BCR stimulation whereas Wilmore et al.[104], showed that silvestrol reduced induction of MYC protein in primary CLL cells following BCR stimulation. Here, BCR is linked to B-cell chronic lymphocytic leukemia.